文献速递临床试验与 GCP

4-氨基吡啶治疗根治性耻骨后前列腺切除术所致神经损伤:单中心双盲随机安慰剂对照研究

4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study.
PubMed 文献 · Trials · 2024-05-21

本研究为单中心、双盲、随机、安慰剂对照临床试验,纳入根治性前列腺切除术后患者,按1:1随机接受4-氨基吡啶(4AP)或安慰剂,主要结局为评估4AP加速术后勃起功能和排尿功能早期恢复至基线的疗效。试验注册号NCT03701581,于2018年10月10日前瞻性注册。

要点

  • 根治性前列腺切除术后勃起功能障碍和尿失禁部分源于神经血管束的创伤性周围神经损伤。
  • 本研究为单中心、双盲、随机、安慰剂对照试验,术后患者按1:1接受4AP或安慰剂。
  • 主要结局为评估4AP加速术后勃起和排尿功能早期恢复至基线的疗效。

核心结论

  • 本研究旨在评估4AP加速根治性前列腺切除术后勃起和排尿功能早期恢复至基线的疗效,原文未报告研究结果。

研究设计与样本

  • 单中心、双盲、随机、安慰剂对照临床试验,根治性前列腺切除术后患者按1:1随机接受4AP或安慰剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate cancer (PCa) is the most common non-cutaneous malignancy in men and leads to the second most common cause of cancer related mortality in men. Early detection of PCa allows for a potentially curative intervention. Most men will live over a decade from the time of their PCa diagnosis. Thus, treatments must balance curative interventions with their impact on quality of life. Radical prostatectomy (RP) is one such potentially curative intervention but often leads to erectile dysfunction (ED) and urinary incontinence (UI). Approximately 90,000 RPs are performed each year in the USA. Post-operative ED and UI is thought to occur in part from traumatic peripheral nerve injury (TPNI) to the neurovascular bundles that surround the prostate. Thus, patients undergoing RP may be a population that would benefit from clinical studies that look at TPNI. METHODS: The study is a single-institution, double-blinded placebo-controlled, randomized clinical trial in which patients immediately post-RP receive either 4-aminopyrdine (4AP) or placebo in a 1:1 fashion. The primary outcome is evaluation of the efficacy of 4AP in accelerating the early return of baseline erectile and urinary function post-radical prostatectomy. DISCUSSION: This study is critical as it could reduce the morbidity associated with RP, a commonly performed operation, and identify a patient population that may greatly benefit into further TPNI research. TRIAL REGISTRATION: ClinicalTrials.gov NCT03701581. Prospectively registered on October 10, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ghazi A, Osinski TL, Feng C, et al. 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study. Trials. 2024. PMID: 38773595. doi:10.1186/s13063-024-08102-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。